The role of glia in late-life depression

International Psychogeriatrics

Volumn 24, Issue 12, 2012, Pages 1878-1890

  Paradise, Matt Bennett ^a   Naismith, Sharon Linda ^a   Norrie, Louisa Margaret ^a   Graeber, Manuel Benedikt ^a   Hickie, Ian Bernard ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

aging; glial cells; immunity; late life depression; major depression; neuroprotection; post mortem

Indexed keywords

C REACTIVE PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMIC ACID; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

AMINO ACID METABOLISM; ANTERIOR CINGULATE; ASTROCYTE; BASAL GANGLION; CELL DENSITY; DISEASE ASSOCIATION; FRONTAL CORTEX; GLIA; GLIOSIS; GRAY MATTER; HIPPOCAMPUS; HUMAN; LATE LIFE DEPRESSION; MICROGLIA; NERVE CELL NETWORK; NEUROIMAGING; NEUROTOXICITY; OLIGODENDROGLIA; ORBITAL CORTEX; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; REVIEW;

AGE OF ONSET; AGED; AUTOPSY; BRAIN; CYTOKINES; DEPRESSIVE DISORDER; ELECTRICAL SYNAPSES; GLIOSIS; GLUTAMIC ACID; HUMANS; INFLAMMATION; NERVE NET; NEUROGLIA; NEUROIMAGING;

EID: 84868252034     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610212000828     Document Type: Review

References (106)

1. Alexander, G. E., DeLong, M. R. and Strick, P. L. (1986). Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annual Review of Neuroscience, 9, 357-381.
2. Alexopoulos, G. S., Meyers, B. S., Young, R. C., Campbell, S., Silbersweig, D. and Charlson, M. (1997). "Vascular depression" hypothesis. Archives of General Psychiatry, 54, 915-922.
3. Allen, N. J. and Barres, B. A. (2009). Neuroscience: glia - more than just brain glue. Nature, 457, 675-677.
4. Almeida, O. P., Norman, P., Hankey, G. J., Jamrozik, K. and Flicker, L. (2007). The association between C-reactive protein concentration and depression in later life is due to poor physical health: results from the Health in Men Study (HIMS). Psychological Medicine, 37, 1775-1786.
5. Araque, A. and Navarrete, M. (2010). Glial cells in neuronal network function. Philosophical Transactions of the Royal Society of London B: Biological Sciences, 365, 2375-2381.
6. Ballmaier, M. et al. (2004). Anterior cingulate, gyrus rectus, and orbitofrontal abnormalities in elderly depressed patients: An MRI-based parcellation of the prefrontal cortex. American Journal of Psychiatry, 161, 99-108.
7. Banasr, M. and Duman, R. S. (2008). Glial loss in the prefrontal cortex is sufficient to induce depressive-like behaviors. Biological Psychiatry, 64, 863-870.
8. Banati, R. and Hickie, I. B. (2009). Therapeutic signposts: using biomarkers to guide better treatment of schizophrenia and other psychotic disorders. Medical Journal of Australia, 190, S26-S32.
9. Banati, R. B. et al. (2000). The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain, 123, 2321-2337.
10. Belmaker, R. H. and Agam, G. (2008). Major depressive disorder. New England Journal of Medicine, 358, 55-68.
11. Berman, R. M. et al. (2000). Antidepressant effects of ketamine in depressed patients. Biological Psychiatry, 47, 351-354.
12. Block, M. L., Zecca, L. and Hong, J. S. (2007). Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nature Reviews Neuroscience, 8, 57-69.
13. Bowley, M. P., Drevets, W. C., Ongur, D. and Price, J. L. (2002). Low glial numbers in the amygdala in major depressive disorder. Biological Psychiatry, 52, 404-412.
14. Bremmer, M. A. et al. (2008). Inflammatory markers in late-life depression: results from a population-based study. Journal of Affective Disorders, 106, 249-255.
15. Brown, W. J. and Bauman, A. E. (2000). Comparison of estimates of population levels of physical activity using two measures. Australian and New Zealand Journal of Public Health, 24, 520-525.
16. Burke, J., McQuoid, D. R., Payne, M. E., Steffens, D. C., Krishnan, R. R. and Taylor, W. D. (2011). Amygdala volume in late-life depression: relationship with age of onset. American Journal of Geriatric Psychiatry, 19, 771-776.
17. Byers, A. L. and Yaffe, K. (2011). Depression and risk of developing dementia. Nature Reviews Neurology, 7, 323-331.
18. Capuron, L., Ravaud, A., Neveu, P. J., Miller, A. H., Maes, M. and Dantzer, R. (2002). Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Molecular Psychiatry, 7, 468-473.
19. Cotter, D., Mackay, D., Landau, S., Kerwin, R. and Everall, I. (2001). Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder. Archives of General Psychiatry, 58, 545-553.
20. Cotter, D., Mackay, D., Chana, G., Beasley, C., Landau, S. and Everall, I. P. (2002). Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cerebral Cortex, 12, 386-394.
21. Cotter, D., Hudson, L. and Landau, S. (2005). Evidence for orbitofrontal pathology in bipolar disorder and major depression, but not in schizophrenia. Bipolar Disorders, 7, 358-369.
22. Davis, S., Thomas, A., Perry, R., Oakley, A., Kalaria, R. N. and O'Brien, J. T. (2002). Glial fibrillary acidic protein in late life major depressive disorder: An immunocytochemical study. Journal of Neurology, Neurosurgery and Psychiatry, 73, 556-560.
23. Delgado, P. L. et al. (1994). Serotonin and the neurobiology of depression: effects of tryptophan depletion in drug-free depressed patients. Archives of General Psychiatry, 51, 865-874.
24. Dentino, A. N. et al. (1999). Association of interleukin-6 and other biologic variables with depression in older people living in the community. Journal of the American Geriatrics Society, 47, 6-11.
25. Dimopoulos, N. et al. (2006). Elevation of plasma concentration of adhesion molecules in late-life depression. International Journal of Geriatric Psychiatry, 21, 965-971.
26. Diniz, B. S., Teixeira, A. L., Talib, L., Gattaz, W. F. and Forlenza, O. V. (2010). Interleukin-1beta serum levels is increased in antidepressant-free elderly depressed patients. American Journal of Geriatric Psychiatry, 18, 172-176.
27. Dowlati, Y. et al. (2010). A meta-analysis of cytokines in major depression. Biological Psychiatry, 67, 446-457.
28. Drevets, W. C., Price, J. L. and Furey, M. L. (2008a). Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Structure and Function, 213, 93-118.
29. Drevets, W. C., Savitz, J. and Trimble, M. (2008b). The subgenual anterior cingulate cortex in mood disorders. CNS Spectrums, 13, 663-681.
30. Duman, R. S. and Monteggia, L. M. (2006). A neurotrophic model for stress-related mood disorders. Biological Psychiatry, 59, 1116-1127.
31. Elderkin-Thompson, V., Hellemann, G., Pham, D. and Kumar, A. (2009). Prefrontal brain morphology and executive function in healthy and depressed elderly. International Journal of Geriatric Psychiatry, 24, 459-468.
32. Eljaschewitsch, E. et al. (2006). The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. Neuron, 49, 67-79.
33. Empana, J. P. et al. (2005). Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: The Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation, 111, 2299-2305.
34. Forti, P. et al. (2010). Blood inflammatory proteins and risk of incident depression in the elderly. Dementia and Geriatric Cognitive Disorders, 29, 11-20.
35. Ginhoux, F. et al. (2010). Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science, 330, 841-845.
36. Gittins, R. A. and Harrison, P. J. (2011). A morphometric study of glia and neurons in the anterior cingulate cortex in mood disorder. Journal of Affective Disorders, 133, 328-332.
37. Graeber, M. B. (2010). Changing face of microglia. Science, 330, 783-788.
38. Graeber, M. B. and Streit, W. J. (1990). Microglia: immune network in the CNS. Brain Pathology, 1, 2-5.
39. Graeber, M. B., Li, W. and Rodriguez, M. L. (2011). Role of microglia in CNS inflammation. FEBS Letters, 585, 3798-3805.
40. Hamidi, M., Drevets, W. C. and Price, J. L. (2004). Glial reduction in amygdala in major depressive disorder is due to oligodendrocytes. Biological Psychiatry, 55, 563-569.
41. Hashimoto, K., Sawa, A. and Iyo, M. (2007). Increased levels of glutamate in brains from patients with mood disorders. Biological Psychiatry, 62, 1310-1316.
42. Hickie, I. B. and Rogers, N. L. (2011). Novel melatonin-based therapies: potential advances in the treatment of major depression. Lancet, 378, 621-631.
43. Hickie, I. and Scott, E. (1998). Late-onset depressive disorders: A preventable variant of cerebrovascular disease? Psychological Medicine, 28, 1007-1013.
44. Hickie, I., Scott, E., Wilhelm, K. and Brodaty, H. (1997). Subcortical hyperintensities on magnetic resonance imaging in patients with severe depression: A longitudinal evaluation. Biological Psychiatry, 42, 367-374.
45. Hickie, I. et al. (1999). Neo-striatal rCBF correlates of psychomotor slowing in patients with major depression. Psychiatry Research, 92, 75-81.
46. Hickie, I. et al. (2005). Reduced hippocampal volumes and memory loss in patients with early- and late-onset depression. British Journal of Psychiatry, 186, 197-202.
47. Hickie, I. B. et al. (2007). Psychomotor slowing in older patients with major depression: relationships with blood flow in the caudate nucleus and white matter lesions. Psychiatry Research: Neuroimaging, 155, 211-220.
48. Hickie, I. B., Naismith, S. L., Norrie, L. M. and Scott, E. M. (2009). Managing depression across the life cycle: new strategies for clinicians and their patients. Internal Medicine Journal, 39, 720-727.
49. Hinwood, M., Morandini, J., Day, T. A. and Walker, F. R. (2011). Evidence that microglia mediate the neurobiological effects of chronic psychological stress on the medial prefrontal cortex. Cerebral Cortex. Epublished ahead of print, doi: 10.1093/cercor/bhr229.
50. Husain, M. M. et al. (1991). A magnetic resonance imaging study of putamen nuclei in major depression. Psychiatry Research, 40, 95-99.
51. Khundakar, A. A. and Thomas, A. J. (2009). Morphometric changes in early- and late-life major depressive disorder: evidence from postmortem studies. International Psychogeriatrics, 21, 844-854.
52. Khundakar, A., Morris, C., Oakley, A., McMeekin, W. and Thomas, A. J. (2009). Morphometric analysis of neuronal and glial cell pathology in the dorsolateral prefrontal cortex in late-life depression. British Journal of Psychiatry, 195, 163-169.
53. Khundakar, A., Morris, C., Oakley, A. and Thomas, A. J. (2011a). Morphometric analysis of neuronal and glial cell pathology in the caudate nucleus in late-life depression. American Journal of Geriatric Psychiatry, 19, 132-141.
54. Khundakar, A., Morris, C., Oakley, A. and Thomas, A. J. (2011b). A morphometric examination of neuronal and glial cell pathology in the orbitofrontal cortex in late-life depression. International Psychogeriatrics, 23, 132-140.
55. Khundakar, A. A., Morris, C. M., Oakley, A. E. and Thomas, A. J. (2011c). Cellular pathology within the anterior cingulate cortex of patients with late-life depression: A morphometric study. Psychiatry Research: Neuroimaging, 194, 184-189.
56. Krishnan, V. and Nestler, E. J. (2010). Linking molecules to mood: new insight into the biology of depression. American Journal of Psychiatry, 167, 1305-1320.
57. Krishnan, K. R., Hays, J. C., Tupler, L. A., George, L. K. and Blazer, D. G. (1995). Clinical and phenomenological comparisons of late-onset and early-onset depression. American Journal of Psychiatry, 152, 785-788.
58. Lee, S. H. et al. (2003). Subcortical lesion severity and orbitofrontal cortex volume in geriatric depression. Biological Psychiatry, 54, 529-533.
59. Lee, J. S., Potter, G. G., Wagner, H. R., Welsh-Bohmer, K. A. and Steffens, D. C. (2007). Persistent mild cognitive impairment in geriatric depression. International Psychogeriatrics, 19, 125-135.
60. Lee, K. S. et al. (2009). Simultaneous measurement of 23 plasma cytokines in late-life depression. Neurological Sciences, 30, 435-438.
61. Leonard, B. E. (2001). The immune system, depression and the action of antidepressants. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 25, 767-780.
62. Li, L., Lu, J., Tay, S. S. W., Moochhala, S. M. and He, B. P. (2007). The function of microglia, either neuroprotection or neurotoxicity, is determined by the equilibrium among factors released from activated microglia in vitro. Brain Research, 1159, 8-17.
63. Mayberg, H. S. (2003). Modulating dysfunctional limbic-cortical circuits in depression: Towards development of brain-based algorithms for diagnosis and optimised treatment. British Medical Bulletin, 65, 193-207.
64. McDonald, J. W., Levine, J. M. and Qu, Y. (1998). Multiple classes of the oligodendrocyte lineage are highly vulnerable to excitotoxicity. Neuroreport, 9, 2757-2762.
65. McNally, L., Bhagwagar, Z. and Hannestad, J. (2008). Inflammation, glutamate, and glia in depression: A literature review. CNS Spectrums, 13, 501-510.
66. Miller, A. H., Maletic, V. and Raison, C. L. (2009). Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression. Biological Psychiatry, 65, 732-741.
67. Naismith, S. et al. (2002). Caudate nucleus volumes and genetic determinants of homocysteine metabolism in the prediction of psychomotor speed in older persons with depression. American Journal of Psychiatry, 159, 2096-2098.
68. Naismith, S. L. et al. (2003). Neuropsychological performance in patients with depression is associated with clinical, etiological and genetic risk factors. Journal of Clinical and Experimental Neuropsychology, 25, 866-877.
69. Naismith, S. L., Hickie, I. B., Ward, P. B., Scott, E. and Little, C. (2006). Impaired implicit sequence learning in depression: A probe for frontostriatal dysfunction? Psychological Medicine, 36, 313-323.
70. Naismith, S. L., Lagopoulos, J., Ward, P. B., Davey, C. G., Little, C. and Hickie, I. B. (2010). Fronto-striatal correlates of impaired implicit sequence learning in major depression: An fMRI study. Journal of Affective Disorders, 125, 256-261.
71. Nestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J. and Monteggia, L. M. (2002). Neurobiology of depression. Neuron, 34, 13-25.
72. Nomura, D. K. et al. (2011). Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation. Science, 334, 809-813.
73. Ongur, D., Drevets, W. C. and Price, J. L. (1998). Glial reduction in the subgenual prefrontal cortex in mood disorders. Proceedings of the National Academy of Sciences of the United States of America, 95, 13290-13295.
74. Pae, C.-U., Marks, D. M., Han, C. and Patkar, A. A. (2008). Does minocycline have antidepressant effect? Biomedicine & Pharmacotherapy, 62, 308-311.
75. Paolicelli, R. C. et al. (2011). Synaptic pruning by microglia is necessary for normal brain development. Science, 333, 1456-1458.
76. Penninx, B. W. et al. (2003). Inflammatory markers and depressed mood in older persons: results from the Health Aging and Body Composition study. Biological Psychiatry, 54, 566-572.
77. Polazzi, E. and Monti, B. (2010). Microglia and neuroprotection: From in vitro studies to therapeutic applications. Progress in Neurobiology, 92, 293-315.
78. Rajkowska, G. (2000). Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biological Psychiatry, 48, 766-777.
79. Rajkowska, G. and Miguel-Hidalgo, J. J. (2007). Gliogenesis and glial pathology in depression. CNS and Neurological Disorders Drug Targets, 6, 219-233.
80. Rajkowska, G. et al. (1999). Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biological Psychiatry, 45, 1085-1098.
81. Rajkowska, G., Miguel-Hidalgo, J. J., Dubey, P., Stockmeier, C. A. and Krishnan, K. R. R. (2005). Prominent reduction in pyramidal neurons density in the orbitofrontal cortex of elderly depressed patients. Biological Psychiatry, 58, 297-306.
82. Sanacora, G. et al. (2004). Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Archives of General Psychiatry, 61, 705-713.
83. Schroeter, M. L., Abdul-Khaliq, H., Krebs, M., Diefenbacher, A. and Blasig, I. E. (2008). Serum markers support disease-specific glial pathology in major depression. Journal of Affective Disorders, 111, 271-280.
84. Schummers, J., Yu, H. and Sur, M. (2008). Tuned responses of astrocytes and their influence on hemodynamic signals in the visual cortex. Science, 320, 1638-1643.
85. Schweitzer, I., Tuckwell, V., Ames, D. and O'Brien, J. (2001). Structural neuroimaging studies in late-life depression: A review. World Journal of Biological Psychiatry, 2, 83-88.
86. Sheline, Y. I., Sanghavi, M., Mintun, M. A. and Gado, M. H. (1999). Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. Journal of Neuroscience, 19, 5034-5043.
87. Si, X., Miguel-Hidalgo, J. J., O'Dwyer, G., Stockmeier, C. A. and Rajkowska, G. (2004). Age-dependent reductions in the level of glial fibrillary acidic protein in the prefrontal cortex in major depression. Neuropsychopharmacology, 29, 2088-2096.
88. Simpson, J. E. et al. (2007). Microglial activation in white matter lesions and nonlesional white matter of ageing brains. Neuropathology and Applied Neurobiology, 33, 670-683.
89. Smith, G. S. et al. (2009). The functional neuroanatomy of geriatric depression. International Journal of Geriatric Psychiatry, 24, 798-808.
90. Sparkman, N. L. and Johnson, R. W. (2008). Neuroinflammation associated with aging sensitizes the brain to the effects of infection or stress. Neuroimmunomodulation, 15, 323-330.
91. Steiner, J. et al. (2011). Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission? Journal of Neuroinflammation, 8, 94.
92. Stockmeier, C. A. et al. (2004). Cellular changes in the postmortem hippocampus in major depression. Biological Psychiatry, 56, 640-650.
93. Thomas, A. J. et al. (2000). Elevation in late-life depression of intercellular adhesion molecule-1 expression in the dorsolateral prefrontal cortex. American Journal of Psychiatry, 157, 1682-1684.
94. Thomas, A. J. et al. (2002). Ischemic basis for deep white matter hyperintensities in major depression: A neuropathological study. Archives of General Psychiatry, 59, 785-792.
95. Thomas, A. J., Davis, S., Morris, C., Jackson, E., Harrison, R. and O'Brien, J. T. (2005). Increase in interleukin-1 beta in late-life depression. American Journal of Psychiatry, 162, 175-177.
96. Tiemeier, H., Hofman, A., van Tuijl, H. R., Kiliaan, A. J., Meijer, J. and Breteler, M. M. (2003). Inflammatory proteins and depression in the elderly. Epidemiology, 14, 103-107.
97. Tikka, T. M. and Koistinaho, J. E. (2001). Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia. Journal of Immunology, 166, 7527-7533.
98. Tremblay, M.-E., Lowery, R. L. andMajewska, A. K. (2010). Microglial interactions with synapses are modulated by visual experience. PLoS Biology, 8, e1000527.
99. Tsopelas, C. M. et al. (2011). Neuropathological correlates of late-life depression in older people. British Journal of Psychiatry, 198, 109-114.
100. Uranova, N. A., Vostrikov, V. M., Orlovskaya, D. D. and Rachmanova, V. I. (2004). Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: A study from the Stanley Neuropathology Consortium. Schizophrenia Research, 67, 269-275.
101. Vaishnavi, S. and Taylor, W. D. (2006). Neuroimaging in late-life depression. International Review of Psychiatry, 18, 443-451.
102. Van Otterloo, E., O'Dwyer, G., Stockmeier, C. A., Steffens, D. C., Krishnan, R. R. and Rajkowska, G. (2009). Reductions in neuronal density in elderly depressed are region specific. International Journal of Geriatric Psychiatry, 24, 856-864.
103. Vercellino, M. et al. (2007). Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: Correlation with microglia infiltration, demyelination, and neuronal and synaptic damage. Journal of Neuropathology and Experimental Neurology, 66, 732-739.
104. Weaver, J. D., Huang, M. H., Albert, M., Harris, T., Rowe, J. W. and Seeman, T. E. (2002). Interleukin-6 and risk of cognitive decline: MacArthur studies of successful aging. Neurology, 59, 371-378.
105. Zarate, C. A., Jr. et al. (2004). An open-label trial of riluzole in patients with treatment-resistant major depression. American Journal of Psychiatry, 161, 171-174.
106. Zorrilla, E. P. et al. (2001). The relationship of depression and stressors to immunological assays: A meta-analytic review. Brain, Behavior and Immunity, 15, 199- 226.